Induction of immune tolerance by dendritic cells: Implications for preventative and therapeutic immunotherapy of autoimmune disease
- 1 December 2002
- journal article
- review article
- Published by Wiley in Immunology & Cell Biology
- Vol. 80 (6) , 509-519
- https://doi.org/10.1046/j.1440-1711.2002.01114.x
Abstract
Dendritic cells (DC) have a key role in controlling the immune response, by determining the outcome of antigen presentation to T cells. Through costimulatory molecules and other factors, DC are involved in the maintenance of peripheral tolerance through modulation of the immune response. This modulation occurs both constitutively, and in inflammation, in order to prevent autoimmunity and to control established immune responses. Dendritic cell control of immune responses may be mediated through cytokine or cell‐contact dependent mechanisms. The molecular and cellular basis of these controls is being understood at an increasingly more complex level. This understanding is reaching a level at which DC‐based therapies for the induction of immune regulation in autoimmunity can be tested in vivo. This review outlines the current state of knowledge of DC in immune tolerance, and proposes how DC might control both T cell responses, and themselves, to prevent autoimmunity and maintain peripheral tolerance.Keywords
This publication has 134 references indexed in Scilit:
- Perforin-independent regulation of dendritic cell homeostasis by CD8+ T cellsin vivo: implications for adaptive immunotherapyEuropean Journal of Immunology, 2001
- Human xenospecific T suppressor cells inhibit T helper cell proliferation to porcine aortic endothelial cells, and NF-κB activity in porcine APCHuman Immunology, 2001
- Self-antigen–presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organsJournal of Clinical Investigation, 2001
- Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy OligodeoxyribonucleotidesMolecular Therapy, 2000
- A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cellsSeminars in Immunology, 2000
- Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In VivoThe Journal of Experimental Medicine, 1998
- Thymic dendritic cellsImmunology Today, 1997
- Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis?Immunology Today, 1996
- TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBαImmunity, 1996
- T cell receptor antagonist peptides induce positive selectionCell, 1994